Confirmation of a metastasis-specific microRNA signature in primary colon cancer

The identification of patients with high-risk stage II colon cancer who may benefit from adjuvant therapy may allow the clinical approach to be tailored for these patients based on an understanding of tumour biology. MicroRNAs have been proposed as markers of the prognosis or treatment response in c...

Descripción completa

Detalles Bibliográficos
Autores principales: Coebergh van den Braak, Robert R. J, Sieuwerts, Anieta M., Lalmahomed, Zarina S., Smid, Marcel, Wilting, Saskia M., Bril, Sandra I., Xiang, Shanshan, van der Vlugt-Daane, Michelle, de Weerd, Vanja, van Galen, Anne, Biermann, Katharina, van Krieken, J. Han J. M, Kloosterman, Wigard P., Foekens, John A., Martens, John W. M., IJzermans, Jan N. M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5869672/
https://www.ncbi.nlm.nih.gov/pubmed/29588449
http://dx.doi.org/10.1038/s41598-018-22532-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5869672/
https://www.ncbi.nlm.nih.gov/pubmed/29588449
http://dx.doi.org/10.1038/s41598-018-22532-1

Ejemplares similares